2,284
Views
10
CrossRef citations to date
0
Altmetric
Author's View

PD-L1 immune suppression in cancer: Tumor cells or host cells?

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: e1325982 | Received 24 Apr 2017, Accepted 26 Apr 2017, Published online: 28 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Misako Matsumoto, Yohei Takeda & Tsukasa Seya. (2020) Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy. Expert Opinion on Biological Therapy 20:8, pages 937-946.
Read now
Adrian Pelin, Jiahu Wang, John Bell & Fabrice Le Boeuf. (2018) The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses. Oncolytic Virotherapy 7, pages 25-35.
Read now

Articles from other publishers (8)

Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, Niels Vandamme, Stephane Plaisance, Annick Verhee, Dominiek Catteeuw, Elke Rogge, Jennifer De Geest, Nele Vanderroost, Jana Roels, Yvan Saeys, Gilles Uzé, Niko Kley, Anje Cauwels & Jan Tavernier. (2023) A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state. Molecular Cancer 22:1.
Crossref
Maciej Gryziak, Krzysztof Wozniak, Leszek Kraj, Letycja Rog & Rafal Stec. (2022) The immune landscape of hepatocellular carcinoma‑where we are? (Review). Oncology Letters 24:5.
Crossref
Thabet AlhousamiMichael DinyFaiza AliJennifer ShinGaurav KumarVikas KumarJoshua D. Campbell, Vikki Noonan, Glenn J. Hanna, Gerald V. Denis, Stefano Monti, Maria A. KukuruzinskaXaralabos Varelas & Manish V. Bais. (2022) Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition. Molecular Cancer Research 20:5, pages 712-721.
Crossref
Yang Hao, Chih Kit Chung, Zhenfeng Yu, Ruben V. Huis in ‘t Veld, Ferry A. Ossendorp, Peter ten Dijke & Luis J. Cruz. (2022) Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy. Pharmaceutics 14:1, pages 120.
Crossref
Sokchea Khou, Alexandra Popa, Carmelo Luci, Franck Bihl, Aida Meghraoui-Kheddar, Pierre Bourdely, Emie Salavagione, Estelle Cosson, Alain Rubod, Julie Cazareth, Pascal Barbry, Bernard Mari, Roger Rezzonico, Fabienne Anjuère & Veronique M. Braud. (2020) Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development. Cancers 12:7, pages 1860.
Crossref
Zuzana Macek Jilkova, Caroline Aspord & Thomas Decaens. (2019) Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges. Cancers 11:10, pages 1554.
Crossref
Dominick G.A. Burton & Alexandra Stolzing. (2018) Cellular senescence: Immunosurveillance and future immunotherapy. Ageing Research Reviews 43, pages 17-25.
Crossref
Misako Matsumoto, Yohei Takeda, Megumi Tatematsu & Tsukasa Seya. (2017) Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy. Frontiers in Immunology 8.
Crossref